Comparison Silexion Therapeutics (SLXN) with Competitors
Silexion Therapeutics (SLXN) industry is Biotechnology.
Debt-to-Equity
SLXN149.83%
Industry28.27%
Upside+430.02%
P/E
SLXN7.30
Industry-20.52
Upside+2781.31%
P/B
SLXN9.13
Industry5.15
Upside+77.39%